Prescriber's Letter

PL Voices: How to Handle Drug Interaction Warnings May 2012

Article: "alert fatigue" caused by the increasing number of drug interaction warnings May 2012

Commentary: Pharmacotherapy of ADHD in Adults February 2012

PL Voices: Adults with ADHD: Cardiovascular Risk and Substance Abuse Considerations February 2012

Article: whether ADHD stimulants increase cardiovascular risk or substance abuse in ADULTS February 2012

Commentary: Drug Interactions With Citalopram (Celexa) January 2012

Article: whether citalopram (Celexa, etc) can be used with oral contraceptives or PPIs January 2012

Article: You'll see ondansetron (Zofran, etc) join the list of drugs with stronger warnings about QT prolongation January 2012

PL Voices: Warfarin vs Pradaxa or Xarelto for Atrial Fib December 2011

Article: comparisons between warfarin, dabigatran (Pradaxa), and rivaroxaban (Xarelto) December 2011

Commentary: Celexa (Citalopram) and QT Interval Prolongation October 2011

PL Voices: Oral Anticoagulants October 2011

Commentary: Multaq (Dronedarone) Alternatives for Atrial Fibrillation October 2011

Article: MORE safety concerns with dronedarone (Multaq) October 2011

Article: citalopram doses should not exceed 40 mg/day for anyone...or 20 mg/day for most patients over age 60 October 2011

Arrhythmias